🔎 Trials Near Me

홈 › 겸형 적혈구증 › 일리노이

일리노이의 겸형 적혈구증 임상 시험

겸형 적혈구증 관련 연구 19개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Uni of Illinois Hospital and HSC, Chicago
피험자 모집 중3상
12세 ~ 100세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • University of Illinois Hospital and Health Sciences System, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Univer Of Illinois at Chicago, Chicago
피험자 모집 중3상
2세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Childrens Hospital of Chicago, Chicago
  • Univer Of Illinois at Chicago, Chicago
피험자 모집 중3상
12세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06612268

Tocilizumab for Acute Chest Syndrome

  • University of Chicago, Chicago
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT05640271

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • University of Illinois at Chicago Clinical Research Center, Chicago
  • University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
  • University of Illinois Hospital and Health Sciences System, Chicago
피험자 모집 중2/3상
12세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT05431088

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Local Institution - 0034, Chicago
피험자 모집 중1/2상건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Rush University Medical Center, Chicago
  • Bleeding and Clotting Disorders Institute, Peoria
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • University of Illinois at Chicago, Chicago
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
피험자 모집 중3상
10세 ~ 65세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT06975865

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

  • University of Illinois at Chicago, Chicago
피험자 모집 중2상
16세 ~ 60세 · 모든 성별 · 2026. 7. 8. 업데이트됨 · NCT03121001

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Comer Children's Hospital (MRD-HCT), Chicago
피험자 모집 중관찰 연구
3세 ~ 20세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT06941389

Sickle Cell Clinical Research and Intervention Program

  • Children's Hospital of Illinois at OSF-Saint Francis Medical Center, Peoria
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT02098863

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

  • University of Illinois Chicago, Sickle Cell Center, Chicago
피험자 모집 중2상
18세 ~ 60세 · 모든 성별 · 2026. 5. 19. 업데이트됨 · NCT07175051

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

  • University of Illinois at Chicago, Chicago
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 3. 23. 업데이트됨 · NCT06919224

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
피험자 모집 중2상
2세 ~ 25세 · 모든 성별 · 2026. 3. 10. 업데이트됨 · NCT03587272

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
피험자 모집 중
16세 ~ 30세 · 모든 성별 · 2026. 1. 7. 업데이트됨 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Illinois, Chicago
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 6. 22. 업데이트됨 · NCT06385886

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

  • University of Illinois at Chicago College of Medicine, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 5. 25. 업데이트됨 · NCT04055818

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.